These inflammatory cells likely contribute to the pathology of obesity-induced lymphatic dysfunction since inhibition of inflammatory reactions with topical IL-2 inhibitors or genetic deficiency of CD4+ T cells decreased the severity of lymphatic injury in obese animals [59]. This evidence concerns the gene IL2 and obesity disorder.